Company Profile: Sana Health
Background
Sana Health is a digital health company founded in 2015 and headquartered in Louisville, Colorado. The company specializes in developing non-invasive, wearable bio-therapeutic devices aimed at alleviating chronic pain, anxiety, and insomnia. Their flagship product, the Sana device, utilizes audiovisual neuromodulation technology to promote relaxation and pain reduction, offering an alternative to traditional medication. The device has received FDA Breakthrough Designation and is undergoing classification for neuropathic pain, with market approval expected in late 2025. Sana Health is actively conducting clinical trials, including studies on PTSD and pain, and is supported by funding from the Department of Defense.
Key Strategic Focus
Sana Health's strategic focus centers on providing non-pharmaceutical solutions for chronic pain management and mental well-being. The company specializes in wearable neurofeedback and audiovisual stimulation devices, targeting conditions such as chronic nerve pain, PTSD, stress, anxiety, and sleep disorders. By leveraging innovative technologies, Sana Health aims to offer accessible and effective alternatives to traditional treatments, enhancing the quality of life for individuals dealing with these conditions.
Financials and Funding
As of December 2025, Sana Health has raised a total of $12.57 million in funding. The most recent funding round occurred on June 15, 2022, securing $60 million. Notable investors include Arch Venture Partners, Flagship Pioneering, CPPIB, and F-Prime Capital. The capital raised is intended to support the company's growth, including the development and market approval of its wearable bio-therapeutic device, as well as the expansion of its clinical trials and research initiatives.
Pipeline Development
Sana Health is advancing its wearable bio-therapeutic device through various stages of development:
- FDA Breakthrough Device Designation: The device has received this designation, facilitating expedited development and review processes.
- Clinical Trials: Ongoing studies are evaluating the device's efficacy in treating conditions such as PTSD and chronic pain.
- Market Approval: The company anticipates FDA market approval for the device in late 2025.
These developments position Sana Health to offer innovative, non-invasive treatment options for individuals suffering from chronic pain and related conditions.
Technological Platform and Innovation
Sana Health's technological platform is distinguished by its proprietary audiovisual neuromodulation technology, which delivers specific pulses of light and sound to induce a deep state of relaxation. This approach aims to alleviate pain and tension without the need for pharmaceutical interventions. The device is designed to provide relief in approximately 10 minutes, offering a convenient and non-invasive treatment option for users.
Leadership Team
Sana Health is led by a team of experienced professionals:
- Richard Hanbury: Founder & CEO.
Under Mr. Hanbury's leadership, the company has secured significant funding and achieved key milestones, including the FDA Breakthrough Device Designation and ongoing clinical trials.
Market Insights and Dynamics
The digital health market, particularly in the realm of wearable bio-therapeutic devices, is experiencing significant growth. Consumers are increasingly seeking non-pharmaceutical solutions for chronic pain management and mental well-being, driving demand for innovative technologies like those developed by Sana Health.
Competitor Analysis
Sana Health operates in a competitive landscape with several notable players:
- Beddit: A company specializing in sleep monitoring devices.
- LumosTech: Focuses on wearable health technology.
- Dreem: Develops sleep-enhancing headbands.
These competitors offer products targeting sleep and relaxation, positioning them in the same market segment as Sana Health.
Strategic Collaborations and Partnerships
Sana Health has engaged in collaborations to advance its product development and clinical research:
- Department of Defense: Secured funding for clinical trials, including studies on PTSD and chronic pain.
These partnerships enhance the company's research capabilities and support the development of its wearable bio-therapeutic device.
Operational Insights
Sana Health differentiates itself through its focus on non-invasive, wearable technology for chronic pain management and mental well-being. The company's innovative approach, combined with strategic partnerships and a clear regulatory pathway, positions it favorably in the growing digital health market.
Strategic Opportunities and Future Directions
Looking ahead, Sana Health aims to:
- Achieve FDA Market Approval: Finalize the approval process for its wearable bio-therapeutic device.
- Expand Clinical Applications: Broaden the device's indications to include additional conditions.
- Enhance Market Penetration: Increase adoption among healthcare providers and consumers seeking non-pharmaceutical treatment options.
These strategic objectives leverage the company's strengths in innovative technology and clinical research to drive future growth.
Contact Information
- Website: sana.io
- LinkedIn: Sana Health
- Twitter: @sana_health
- Facebook: Sana Health
- Instagram: @sanahealth
- YouTube: Sana Health
These channels provide avenues for stakeholders to engage with the company and stay informed about its developments.
